Our research pipeline highlights the unmet medical needs each program addresses, along with research undertaken in our laboratories and those of our collaborators to address these challenges. To date, two of TSRLab’s technologies have been successfully out-licensed, and we have secured more than $21 million to invest in our portfolio assets.

We are actively seeking partner investments and research collaborations to expand our portfolio of antiviral compounds and drug delivery technologies. Learn more about partnering with TSRLabs.